Truveta Launches Real-World Data Platform to Accelerate Clinical Trials

Truveta has shared an update. The company has launched a new clinical trials offering aimed at improving trial design, execution, and evidence generation by leveraging daily updated, longitudinal real-world data. The platform integrates complete electronic health record (EHR) data, including clinical notes and images, with linked claims and social determinants of health, and is developed in collaboration with health system partners. The new solution is positioned to help trial sponsors assess protocol feasibility in real time, monitor recruitment and site performance, reduce amendments and underperforming sites, and support generation of regulatory-grade evidence with long-term follow-up.

For investors, this expansion deepens Truveta’s role in the clinical research and real-world evidence (RWE) market, a segment seeing increasing demand from biopharma, medtech, and regulators seeking richer data for trial optimization and post-marketing studies. If adopted at scale by sponsors, the offering could create new recurring revenue streams tied to trial design, site selection, and evidence services, while strengthening data-sharing relationships with health systems. The emphasis on daily refreshed EHR data and linkage to claims and social drivers may differentiate Truveta in a competitive landscape that includes established RWE and data analytics providers. Execution risk will center on Truveta’s ability to demonstrate measurable improvements in enrollment speed, protocol efficiency, and regulatory acceptance of its evidence, which will determine the platform’s pricing power and long-term growth potential in the clinical development value chain.